Drug relieves persistent daydreaming, fatigue, and brain sluggishness in adults with ADHD

  Tests of a drug known to stimulate brain activity have shown early success in reducing symptoms of sluggish cognitive tempo in 38 men and women with attention deficit hyperactivity disorder (ADHD.) A collection of symptoms including persistent dreaminess, fatigue, and slow-working speed, sluggish cognitive tempo has been a subject of debate over whether it is part of, or separate from, ADHD. Researchers at NYU Grossman School of Medicine and Icahn School of Medicine at Mount Sinai who led the study say the stimulant lisdexamfetamine (sold as Vyvanse) reduced by 30 percent self-reported symptoms of sluggish cognitive tempo. It also lowered by over 40 percent symptoms of ADHD and significantly corrected deficits in executive brain function, with fewer episodes of procrastination, improvements in keeping things in mind, and strengthened prioritization skills. Publishing in the  Journal of Clinical Psychiatry  online June 29, the study also showed that one-quarter of the overall improvem

Cambridge University Researchers Use AI to Find 200 Drugs For COVID Treatment

  Researchers at Cambridge University say that they have used AI to find 200 potential drugs that can treat COVID-19. With the coronavirus pandemic still not over, researchers are working on ways in which to limit the harms caused by COVID, and scientists in the UK said that using a combination of computational biology and machine learning, they were able to study proteins and identify ones that were linked to the SARS-CoV-2 infection. The researchers at the university's Milner Therapeutics Institute used AI to examine the protein network and identified those that led to the infection.They said that this helped to determine 200 potential drugs that can be used to treat COVID-19 of which some are already being tested. The researchers studied nearly 2,000 approved drugs for their effectiveness against COVID-19 and identified 200 of them for use against the disease. Out of this, 40 of the drugs have already been entered into clinical trials to fight COVID-19. The researchers say that